Coronary collaterals remain recruitable after percutaneous intervention.
Divaka Perera1, Gajen S Kanaganayagam, Mrinal Saha
1Cardiovascular Division, Rayne Institute, St Thomas' Hospital Campus, King's College, London, UK.
Circulation
|April 4, 2007
Summary
Coronary collateral flow remains stable for 24 hours post-PCI but declines significantly by 6 months. Circulating stem cells correlate with collateral function after intervention.
Area of Science:
- Cardiovascular Research
- Interventional Cardiology
- Vascular Biology
Background:
- Percutaneous coronary intervention (PCI) can lead to rapid loss of collateral support, increasing myocardial infarction risk.
- Well-developed coronary collaterals exist even without ischemic stimuli, indicating inherent plasticity.
- Understanding collateral supply dynamics post-PCI is crucial for managing myocardial perfusion.
Purpose of the Study:
- To assess the plasticity and determinants of coronary collateral supply after PCI.
- To evaluate changes in collateral flow index (CFI) over time post-PCI.
- To identify factors influencing collateral function, including lesion characteristics and circulating hemopoietic cells.
Main Methods:
- Calculated collateral flow index (CFI) using pressure measurements (aortic, central venous, coronary wedge).
- Measured CFI at baseline, 5 minutes, 24 hours, and 6 months after successful PCI in 60 patients.
- Assessed relationships between CFI, coronary lesion severity, and circulating CD133+ and CD34+ cells.
Main Results:
- CFI remained unchanged at 5 minutes and 24 hours post-PCI.
- CFI significantly decreased by 6 months, representing 63% of baseline values (P<0.001).
- Baseline CFI correlated with lesion severity, but this association was lost at 6 months. Circulating CD133+ and CD34+ cells correlated with 6-month CFI.
Conclusions:
- Coronary collateral flow is maintained for at least 24 hours after successful PCI.
- Functional collateral support diminishes significantly by 6 months post-PCI but does not completely regress.
- Circulating hemopoietic stem cells may play a role in maintaining collateral function long-term after PCI.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522


